Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.395 -0.0  -3.7%

Last Trade - 05/03/21

Sector
Healthcare
Size
Micro Cap
Market Cap £11.5m
Enterprise Value £6.71m
Revenue £n/a
Position in Universe 1532nd / 1850

BRIEF-Cereno Scientific And OCT Sign Contract For Phase II Study In Patients Undergoing Knee Replacement

Wed 12th September, 2018 9:04am
Sept 12 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC AND OCT SIGN CONTRACT FOR THE CONDUCT OF A PHASE II STUDY IN PATIENTS
UNDERGOING KNEE REPLACEMENT
    * APPLICATIONS TO REGULATORY AUTHORITIES TO CONDUCT STUDY ARE EXPECTED TO BE SUBMITTED IN Q4
2018

Source text for Eikon:  ID:nWkr1YBmBq 
Further company coverage:  CRNOSb.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.